Top

Published in:

Open Access 01-07-2021 | Gastroesophageal Reflux Disease | Dynamic Manuscript

Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study

Authors: Zhi-Tong Li, Feng Ji, Xin-Wei Han, Rui Zhang, Li-Dong Chen, Chun-Xia Li, Li-Li Yuan, Zhong-Gao Wang, Kang-Dong Liu

Published in: Surgical Endoscopy | Issue 7/2021

Abstract

Background

Gastroesophageal reflux disease (GERD) is a common digestive disease, could cause extra-esophageal symptoms. Peroral endoscopic cardial constriction with band ligation (PECC-b) is a minimally invasive method for the treatment of GERD in recent years. The goals of this study were to evaluate the clinical efficacy of PECC-b to treat gastroesophageal reflux-related symptoms.

Methods

A retrospective study of patients undergoing PECC-b between January 2017 and December 2018 at a single institution was conducted. All patients confirmed GERD by endoscopy, esophageal PH-impedance monitoring, esophageal manometry and symptom questionnaires. The outcome measures included reflux-related scores, patients’ satisfaction and drug independence after 12 months following surgery.

Results

A total of 68 patients, with follow-up of 12 months post surgery, were included in the final analysis. The symptom scores were all significantly decreased as compared with preoperation (P < 0.05). The esophageal symptom scores showed a better improvement than extra-esophageal symptoms (P < 0.001). Fifty-three (77.9%) patients achieved complete drug therapy independence and 52 (76.5%) patients were completely or partially satisfied with the symptom relief following surgery.

Conclusions

The PECC-b is a safe, effective and recommended approach for the control of GERD-related symptoms. Further multicenter prospective studies are required to confirm these outcomes.

Available only for authorised users

Lassen A, Hallas J, de Muckadell OB (2006) Esophagitis: incidence and risk of esophageal adenocarcinoma—a population-based cohort study. Am J Gastroenterol 101:1193–1199PubMedCrossRef

Hungin AP, Raghunath A, Wiklund I (2005) Beyond heartburn: a review of the spectrum of reflux-induced disease. Fam Pract 22:591–603PubMedCrossRef

Sontag SJ (2000) Gastroesophageal reflux disease and asthma. J Clin Gastroenterol (Suppl 3):S9–30.

Lux G, Van Els J, The GS, Bozkurt T, Orth KH, Behrenbeck D (1995) Ambulatory oesophageal pressure, pH and ECG recording in patients with normal and pathological coronary angiography and intermittent chest pain. Neurogastroenterol Motil 7:23–30PubMedCrossRef

Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD (2010) SAGES Guidelines Committee. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24(11):2647–2669

Richter JE (2013) Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 11(5):465–471PubMedCrossRef

Franciosa M, Mashimo H (2013) Stretta radiofrequency treatment for GERD: a safe and effective modality. Am J Gastroenterol 108(10):1654–1655PubMedCrossRef

Inoue H, Ito H, Ikeda H, Sato C, Sato H, Chainarong Phalanusitthepha C, Hayee B, Eleftheriadis N, Kudo S (2014) Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol 27:346–351PubMedPubMedCentral

Nabi Z, Reddy DN (2019) Update on endoscopic approaches for the management of gastroesophageal reflux disease. Gastroenterol Hepatol (N Y) 15(7):369–376

10.

Pearl J, Pauli E, Dunkin B, Stefanidis D (2017) SAGES endoluminal treatments for GERD. Surg Endosc 31:3783–3790PubMedCrossRef

11.

Li X, Zhang XB, Hu HQ, Li HK, Wang XX, Linghu EQ (2017) Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease. Chin Med J (Engl) 130(14):1749–1750CrossRef

12.

Hu HQ, Li HK, Xiong Y, Zhang XB, Zhi JL, Wang XX, Ling-Hu EQ (2018) Peroral endoscopic cardial constriction in gastroesophageal reflux disease. Medicine (Baltimore) 97(15):e169

13.

Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P (2001) Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 96:52–57PubMedCrossRef

14.

Liang WT, Wang ZG, Wang F, Yang Y, Hu ZW, Liu JJ, Zhu GC, Zhang C, Wu JM (2014) Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterol 10(14):178CrossRef

15.

Li ZT, Ji F, Han XW, Gu LX, Wang L, Yue YQ, Wang ZG (2018) Contribution of hiatal hernia to asthma in patients with gastroesophageal reflux disease. Clin Respir J 12(5):1858–1864PubMedCrossRef

16.

Cowgill SM, Al-Saadi S, Villadolid D, Zervos EE, Rosemurgy A (2006) Does Barrett’s esophagus impact outcome after laparoscopic Nissen fundoplication? Am J Surg 192:622–626PubMedCrossRef

17.

Wilson NM, Charette L, Thompson AL, Silverman M (1985) Gastroesophageal reflux and childhood asthma: the acid test. Thorax 40:592–597PubMedPubMedCentralCrossRef

18.

Kerr P, Shoenut JP, Millar T, Buckle P, Kryger MH (1992) Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest 101(6):1539–1544PubMedCrossRef

19.

Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R (2006) Global Consensus Group. The Montreal definition and classification of gastro-esophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920PubMedCrossRef

20.

Chapman DB, Rees CJ, Lippert D, Sataloff RT, Wright SC Jr (2011) Adverse effects of long-term proton pump inhibitor use: a review for the otolaryngologist. J Voice 25(2):236–240PubMedCrossRef

21.

Cicala M, Emerenziani S, Guarino MP, Ribolsi M (2013) Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol 19(39):6529–6535PubMedPubMedCentralCrossRef

22.

Mermelstein J, Chait Mermelstein A, Chait MM (2018) Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions. Clin Exp Gastroenterol 21(11):119–134CrossRef

23.

Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA (2009) Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360:1487–1499PubMedPubMedCentralCrossRef

24.

Wilshire CL, Watson TJ (2013) Surgical management of gastroesophageal reflux disease. Gastroenterol Clin N Am 42(1):119–131CrossRef

25.

Booth MI, Jones L, Stratford J, Dehn TC (2002) Results of laparoscopic Nissen fundoplication at 2–8 years after surgery. Br J Surg 89:476–481PubMedCrossRef

26.

Yasuda A, Yasuda T, Imamoto H, Kato H, Nishiki K, Iwama M, Makino T, Shiraishi O, Shinkai M, Imano M, Furukawa H, Okuno K, Shiozaki H (2015) A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomy. Gastric Cancer 18:850–858PubMedCrossRef

27.

Takahashi T, Yoshida M, Kubota T, Otani Y, Saikawa Y, Ishikawa H, Suganuma K, Akatsu Y, Kumai K, Kitajima M (2005) Morphologic analysis of gastroesophageal reflux diseases in patients after distal gastrectomy. World J Surg 29:50–57PubMedCrossRef

28.

Hedberg HM, Kuchta K, Ujiki MB (2019) First experience with banded anti-reflux mucosectomy (ARMS) for GERD: feasibility, safety, and technique (With Video). J Gastrointest Surg 23(6):1274–1278PubMedCrossRef

29.

Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, Lind T (2009) Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 30:1030–1038PubMedCrossRef

30.

Jonasson C, Moum B, Bang C, Andersen KR, Hatlebakk JG (2012) Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD. Aliment Pharmacol Ther 35:1290–1300PubMedCrossRef

31.

Li Z-T, Ji F, Han X-W, Yuan LL, Wu ZY, Xu M, Peng DL, Wang ZG (2019) Role of fundoplication in treatment of patients with symptoms of hiatal hernia. Sci Rep 9:125–144CrossRef

Title: Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study
Authors: Zhi-Tong Li
Feng Ji
Xin-Wei Han
Rui Zhang
Li-Dong Chen
Chun-Xia Li
Li-Li Yuan
Zhong-Gao Wang
Kang-Dong Liu
Publication date: 01-07-2021
Publisher: Springer US
Keyword: Gastroesophageal Reflux Disease
Published in: Surgical Endoscopy / Issue 7/2021
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-021-08397-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2021

Zenker diverticulum treatment: retrospective comparison of flexible endoscopic window technique and surgical approaches

The effect of smoking on bariatric surgical 30-day outcomes: propensity-score-matched analysis of the MBSAQIP

Dual common bile duct examination with transcystic choledochoscopy and cholangiography in laparoscopic cholecystectomy for suspected choledocholithiasis: a prospective study

Comparison of clinical outcomes and quality of life between laparoscopic distal pancreatectomy with or without spleen preservation

Surgical Coaching for Operative Performance Enhancement (SCOPE): skill ratings and impact on surgeons’ practice

Establishment of a per oral endoscopic myotomy program at a rural tertiary care center